0000939767-20-000128.txt : 20200910 0000939767-20-000128.hdr.sgml : 20200910 20200910203936 ACCESSION NUMBER: 0000939767-20-000128 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200908 FILED AS OF DATE: 20200910 DATE AS OF CHANGE: 20200910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hessekiel Jeffrey CENTRAL INDEX KEY: 0001599803 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 201169730 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_159978475973402.xml FORM 4 X0306 4 2020-09-08 0 0000939767 EXELIXIS, INC. EXEL 0001599803 Hessekiel Jeffrey C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 0 1 0 0 EVP and General Counsel Common Stock 2020-09-08 4 M 0 59692 1.90 A 313692 D Common Stock 2020-09-08 4 M 0 190000 6.21 A 503692 D Common Stock 2020-09-08 4 F 0 160666 20.71 D 343026 D Common Stock 999 I By 401(k) Option (right to buy) 1.9 2020-09-08 4 M 0 59692 0 D 2015-07-20 2022-02-04 Common Stock 59692.0 20000 D Option (right to buy) 6.21 2020-09-08 4 M 0 190000 0 D 2016-09-16 2022-09-15 Common Stock 190000.0 0 D Includes 39,058 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units. Represents a "net exercise" of outstanding stock options. The Reporting Person received 89,026 shares of Common Stock on the net exercise of stock options to purchase 249,692 shares of Common Stock. The Issuer withheld 160,666 shares of Common Stock underlying the stock options for payment of the exercise prices and tax withholdings using a stock price on September 8, 2020 of $20.71. Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 8, 2020. The option, representing the right to purchase a total of 200,000 shares of Common Stock, became fully exercisable on April 28, 2016. The option, representing the right to purchase a total of 190,000 shares of Common Stock, became fully exercisable on September 16, 2019. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2020-09-10